Compare MNKD & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNKD | MBIN |
|---|---|---|
| Founded | 1991 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2004 | 2017 |
| Metric | MNKD | MBIN |
|---|---|---|
| Price | $5.68 | $34.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $10.08 | ★ $39.67 |
| AVG Volume (30 Days) | ★ 3.3M | 194.0K |
| Earning Date | 11-05-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 1.17% |
| EPS Growth | ★ 23.47 | N/A |
| EPS | 0.10 | ★ 4.34 |
| Revenue | $313,787,000.00 | ★ $597,247,000.00 |
| Revenue This Year | $21.54 | $5.57 |
| Revenue Next Year | $22.21 | $8.80 |
| P/E Ratio | $57.92 | ★ $7.84 |
| Revenue Growth | ★ 17.43 | N/A |
| 52 Week Low | $3.38 | $27.25 |
| 52 Week High | $6.68 | $43.82 |
| Indicator | MNKD | MBIN |
|---|---|---|
| Relative Strength Index (RSI) | 48.22 | 49.50 |
| Support Level | $5.56 | $33.28 |
| Resistance Level | $6.12 | $34.01 |
| Average True Range (ATR) | 0.17 | 0.96 |
| MACD | -0.04 | -0.33 |
| Stochastic Oscillator | 20.51 | 25.78 |
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.